← back to search

Aggrey Semeere

Infectious Diseases Institute · UG
Area of research
Infectious Diseases · Oncology
Research interest
Research interests include HIV/AIDS Research and Interventions, Viral-associated cancers and disorders, HIV Research and Treatment, and HIV-related health complications and treatments.
h-index
18
citations
1,001
works
120
NIH funding
primary concept
email

Recent publications

Emerging Trends in Point-of-Care Technology Development for Oncology in Low- and Middle-Income Countries
JCO Global Oncology 2025cited by 9position: middledoi
Drug Resistance in People With Viremia on Dolutegravir-based Antiretroviral Therapy in Sub-Saharan Africa: The DTG RESIST Study
Clinical Infectious Diseases 2025cited by 8position: middledoi
Understanding Diagnostic Delays for Kaposi Sarcoma in Kenya: A Qualitative Study
JAIDS Journal of Acquired Immune Deficiency Syndromes 2022cited by 11position: middledoi
Gaps in TB preventive therapy for persons initiating antiretroviral therapy in Uganda: an explanatory sequential cascade analysis
The International Journal of Tuberculosis and Lung Disease 2021cited by 25position: middledoi
Low-cost, chromatic confocal endomicroscope for cellular imaging in vivo
Biomedical Optics Express 2021cited by 21position: middledoi
A portable device for nucleic acid quantification powered by sunlight, a flame or electricity
Nature Biomedical Engineering 2018cited by 89position: middledoi
Smartphone confocal microscopy for imaging cellular structures in human skin in vivo
Biomedical Optics Express 2018cited by 62position: middledoi
Updating vital status by tracking in the community among patients with epidemic Kaposi sarcoma who are lost to follow-up in sub-Saharan Africa
BMC Cancer 2017cited by 20position: firstdoi
A prospective ascertainment of cancer incidence in sub‐Saharan Africa: The case of Kaposi sarcoma
Cancer Medicine 2016cited by 60position: firstdoi
Impact of antiretroviral therapy on the incidence of Kaposi's sarcoma in resource-rich and resource-limited settings
Current Opinion in Oncology 2012cited by 61position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Jeffrey N. Martin · Global Solutions for Infectious Diseases5 papers (2012–2022)Esther E. Freeman · Harvard University4 papers (2017–2022)Toby Maurer · Indiana University School of Medicine3 papers (2016–2022)Naftali Busakhala · Indiana University School of Medicine3 papers (2012–2022)Miriam Laker‐Oketta · Infectious Diseases Institute2 papers (2016–2022)David V. Glidden · San Francisco General Hospital2 papers (2016–2017)Kara Wools‐Kaloustian · AMPATH2 papers (2016–2017)David Erickson · Cornell University2 papers (2018–2025)Helen Byakwaga · Mbarara University of Science and Technology2 papers (2022–2025)Andrew Kambugu · Indiana University – Purdue University Indianapolis2 papers (2016–2021)Constantin T. Yiannoutsos · City University of New York2 papers (2016–2017)Winnie Muyindike · Indiana University – Purdue University Indianapolis2 papers (2016–2025) · 2 papers (2016–2021)Matthias Egger · Ludwig-Maximilians-Universität München2 papers (2017–2025)Dongkyun Kang · University of Arizona2 papers (2018–2021)Megan Wenger · University of California, San Francisco2 papers (2016–2017)Mwebesa Bwana · Indiana University – Purdue University Indianapolis2 papers (2016–2017)Varun Kopparthy · Piedmont International University1 papers (2018–2018)Emmanuel Oga · The Ohio State University1 papers (2017–2017)Clement Adebamowo · University of Maryland, Baltimore1 papers (2017–2017)